Ranjana Advani
Stanford University School of Medicine
Ranjana Advani
Stanford University School of Medicine
Ranjana H. Advani, MD is the Saul Rosenberg Professor of Lymphoma and serves as the Physician Leader of the Lymphoma Clinical Care Program. She specializes in research and treatment of Hodgkin and non-Hodgkin lymphomas and has developed a broad collaborative investigative program, encompassing clinical trials and translational correlates. She is the Principle Investigator on numerous clinical trials. She currently serves on the National Comprehensive Cancer Network (NCCN) non Hodgkin and Hodgkin Lymphoma (vice chair) guidelines panel, Lymphoma Core Committee of the Eastern Cooperative Oncology Group (ECOG) and the National Cancer Institute Lymphoma Steering Committee.
Topic: Risk Stratification and Therapeutic Approach for First line Hodgkin Lymphoma
Ranjana Advani
Stanford University School of Medicine
Brad Kahl
Washington University School of Medicine
Brad Kahl
Washington University School of Medicine
Dr. Kahl is an associate professor of medicine at the University of Wisconsin School of Medicine and Public Health. He is the director of the UW Lymphoma Service and clinical research director for hematologic malignancies at the Paul P. Carbone Comprehensive Cancer Center. He received his medical degree from Tufts University where he was elected AOA. He completed all post-graduate training at the University of Wisconsin and was appointed to the faculty in 2000.
Topic: Recent advances in lymphoma clinical trials
Brad Kahl
Washington University School of Medicine
UK OFFICE
US OFFICE